ArticleAntimicrobial agents and chemotherapy2018
Coidentification of
Article in Antimicrobial agents and chemotherapy, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
26 citing papers in PubMed, 50 citations in OpenAlex.
- Genomic analysis of MCR-8 and NDM-5 coproducingBiosafety and health · 2026Article
- Trends in Colistin Resistance and Multidrug-Resistant Phenotypes Among Gram-Negative Bacilli: A Retrospective Analysis.Molecules (Basel, Switzerland) · 2025Article
- The multifaceted roles of phosphoethanolamine-modified lipopolysaccharides: from stress response and virulence to cationic antimicrobial resistance.Microbiology and molecular biology reviews : MMBR · 2024Review
- More thanFrontiers in cellular and infection microbiology · 2023Article
- Molecular epidemiology and genomic characterization of a plasmid-mediatedComputational and structural biotechnology journal · 2023Article
- Prevalence and Distribution ofAntimicrobial agents and chemotherapy · 2022Article
- Longitudinal Study Detects the Co-Carriage of ESBL andAnimals : an open access journal from MDPI · 2022Article
- Global epidemiology, genetic environment, risk factors and therapeutic prospects ofFrontiers in cellular and infection microbiology · 2022Review
- Complete Genetic Analysis of Plasmids Carried by Two NonclonalMicrobiology spectrum · 2021Article
- Characterization of resistance mechanisms of Enterobacter cloacae Complex co-resistant to carbapenem and colistin.BMC microbiology · 2021Article
- Antimicrobial Resistance Profile ofJournal of microbiology and biotechnology · 2021Article
- Emergence of the Coexistence ofInfection and drug resistance · 2021Article
- Current Update on Intrinsic and Acquired Colistin Resistance Mechanisms in Bacteria.Frontiers in medicine · 2021Review
- Emerging Transcriptional and Genomic Mechanisms Mediating Carbapenem and Polymyxin Resistance inmSystems · 2020Review
- Harnessing efficient multiplex PCR methods to detect the expanding Tet(X) family of tigecycline resistance genes.Virulence · 2020Article
- Article
- MgrB Inactivation Is Responsible for Acquired Resistance to Colistin in Enterobacter hormaechei subsp.Antimicrobial agents and chemotherapy · 2020Article
- Retrospective Screening and Analysis ofFrontiers in microbiology · 2020Article
- A novel plasmid-encoded mcr-4.3 gene in a colistin-resistant Acinetobacter baumannii clinical strain.The Journal of antimicrobial chemotherapy · 2020Article
- An overview of colistin resistance, mobilized colistin resistance genes dissemination, global responses, and the alternatives to colistin: A review.Veterinary world · 2019Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors at 4 institutions in 2 countries.
Funding
Abstract
We describe the first report of a clinical colistin-resistant ST84
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.